RENOCIS

This brand name is authorized in France, Ireland, Spain, UK.

Active ingredients

The drug RENOCIS contains one active pharmaceutical ingredient (API):

1
UNII DX1U2629QE - SUCCIMER
 
Read more about Technetium ⁹⁹ᵐTc succimer

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 RENOCIS Kit for radiopharmaceutical preparation MPI, EU: SmPC Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V09CA02 Technetium (99mTc) succimer V Various → V09 Diagnostic radiopharmaceuticals → V09C Renal system → V09CA Technetium (99mTc) compounds
Discover more medicines within V09CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
ES Centro de información online de medicamentos de la AEMPS 69828
FR Base de données publique des médicaments 62717286
GB Medicines & Healthcare Products Regulatory Agency 393362

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈